Dominant host range selection of vaccinia recombinants by rescue of an essential gene

Virology

Volumn 249, Issue 1, 1998, Pages 160-166

  Holzer, Georg W ^a   Gritschenberger, Werner ^a   Mayrhofer, Josef A ^a   Wieser, Verena ^a   Dorner, Friedrich ^a   Falkner, Falko G ^a  

^a BAXTER INNOVATIONS GMBH   (Austria)

Author keywords

[No Author keywords available]

Indexed keywords

PLASMID VECTOR; THYMIDINE KINASE; URACIL DNA GLYCOSYLTRANSFERASE;

ANIMAL CELL; ARTICLE; CONTROLLED STUDY; DEFECTIVE VIRUS; GENE EXPRESSION; NONHUMAN; PRIORITY JOURNAL; VACCINIA VIRUS; VIROGENESIS; VIRUS GENE; VIRUS PLAQUE; VIRUS RECOMBINANT;

ANIMALIA; DNA VIRUSES; RNA VIRUSES; VACCINIA; VACCINIA VIRUS;

EID: 0032530894     PISSN: 00426822     EISSN: None     Source Type: Journal    
DOI: 10.1006/viro.1998.9307     Document Type: Article

References (33)

1. Blasco R., Moss B. Selection of recombinant vaccinia viruses on the basis of plaque formation. Gene. 158:1995;157-162.
2. Boyle D. B., Coupar B. E. A dominant selectable marker for the construction of recombinant poxviruses. Gene. 65:1988;123-128.
3. Carroll M. W., Moss B. E. coli. BioTechniques. 19:1995;352-356.
4. Carroll M. W., Moss B. Poxviruses as expression vectors. Curr. Opin. Biotechnol. 8:1997;573-577.
5. Chakrabarti S., Brechling K., Moss B. Vaccinia virus expression vector: coexpression of beta-galactosidase provides visual screening of recombinant virus plaques. Mol. Cell. Biol. 5:1985;3403-3409.
6. Chakrabarti S., Sisler J. R., Moss B. Compact, synthetic, vaccinia virus early/late promoter for protein expression. BioTechniques. 21:1998;1904-1907.
7. Condit R. C., Motyczka A., Spizz G. Isolation, characterization, and physical mapping of temperature-sensitive mutants of vaccinia virus. Virology. 128:1983;429-443.
8. Ensinger M. J. Isolation and genetic characterization of temperature-sensitive mutants of vaccinia virus WR. J. Virol. 43:1982;778-790.
9. Evans E., Traktman P. Molecular genetic analysis of a vaccinia virus gene with an essential role in DNA replication. J. Virol. 61:1987;3152-3162.
10. Falkner F. G., Moss B. Escherichia coli. J. Virol. 62:1988;1849-1854.
11. Franke C. A., Rice C. M., Strauss J. H., Hruby D. E. Neomycin resistance as a dominant selectable marker for selection and isolation of vaccinia virus recombinants. Mol. Cell. Biol. 5:1985;1918-1924.
12. Graham F. L., van der Eb A. J. A new technique for the assay of infectifity of human adenovirus 5 DNA. Virology. 52:1973;456-467.
13. Holzer G. W., Falkner F. G. Construction of a vaccinia virus deficient in the essential DNA repair enzyme uracil DNA glycosylase by a complementing cell line. J. Virol. 71:1997;4997-5002.
14. Isaacs S. N., Kotwal G. J., Moss B. Reverse guanine phosphoribosyltransferase selection of recombinant vaccinia viruses. Virology. 178:1990;626-630.
15. Johnson G. P., Goebel S. J., Paoletti E. An update on the vaccinia virus genome. Virology. 196:1993;381-401.
16. Joklik W. K. The purification of four strains of poxvirus. Virology. 18:1962;9-18.
17. Lee-Chen G. J., Bourgeois N., Davidson K., Condit R. C., Niles E. G. Structure of the transcription initiation and termination sequences of seven early genes in the vaccinia virus HindIII D fragment. Virology. 163:1988;64-79.
18. Mackett M., Smith G. L., Moss B. Vaccinia virus: a selectable eukaryotic cloning and expression vector. Proc. Natl. Acad. Sci. USA. 79:1982;7415-7419.
19. Millns A. K., Carpenter M. S., DeLange A. M. The vaccinia virus-encoded uracil DNA glycosylase has an essential role in viral DNA replication. Virology. 198:1994;504-513.
20. Moss B. Genetically engineered poxviruses for recombinant gene expression, vaccination, and safety. Proc. Natl. Acad. Sci. USA. 93:1996a;11341-11348.
21. Moss, B. 1996b, Poxviridae: the viruses and their replication, In, Fields Virology, Raven Press, Philadelphia.
22. Panicali D., Paoletti E. Construction of poxviruses as cloning vectors: insertion of the thymidine kinase gene from herpes simplex virus into the DNA of infectious vaccinia virus. Proc. Natl. Acad. Sci. USA. 79:1982;4927-4931.
23. Paoletti E. Applications of pox virus vectors to vaccination: an update. Proc. Natl. Acad. Sci. USA. 93:1996;11349-11353.
24. Pedley C. B., Cooper R. J. The assay, purification and properties of vaccinia virus-induced uncoating protein. J. Gen. Virol. 68:1987;1021-1028.
25. Perkus M. E., Limbach K., Paoletti E. Cloning and expression of foreign genes in vaccinia virus, using a host range selection system. J. Virol. 63:1989;3829-3836.
26. Pfleiderer M., Falkner F. G., Dorner F. Requirements for optimal expression of secreted and non-sected recombinant proteins in vaccinia virus systems. Prot. Exp. Purif. 6:1995;559-569.
27. Rodriguez J. F., Esteban M. Plaque size phenotype as a selectable marker to generate vaccinia virus recombinants. J. Virol. 63:1989;997-1001.
28. Roseman N. A., Hruby D. E. Nucleotide sequence and transcript organization of a region of the vaccinia virus genome which encodes a constitutively expressed gene required for DNA replication. J. Virol. 61:1987;1398-1406.
29. Scheiflinger F., Dorner F., Falkner F. G. Transient marker stabilisation: a general procedure to construct marker-free recombinant vaccinia virus. Arch. Virol. 143:1998;467-474.
30. Stuart D. T., Upton C., Higman M. A., Niles E. G., McFadden G. A poxvirus-encoded uracil DNA glycosylase is essential for virus viability. J. Virol. 67:1993;2503-2512.
31. Towbin H., Staehelin T., Gordon J. Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some applications. Proc. Natl. Acad. Sci. USA. 76:1979;4350-4354.
32. Upton C., Stuart D. T., McFadden G. Identification of a poxvirus gene encoding a uracil DNA glycosylase. Proc. Natl. Acad. Sci. USA. 90:1993;4518-4522.
33. Zhou J., Crawford L., Sun X. Y., Frazer I. H. The hygromycin-resistance-encoding gene as a selection marker for vaccinia virus recombinants. Gene. 107:1991;307-312.